These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 13829149)

  • 1. Suppression of uric acid synthesis in the gouty human by the use of 6-diazo-5-oxo-L-norleucine.
    GRAYZEL AI; SEEGMILLER JE; LOVE E
    J Clin Invest; 1960 Mar; 39(3):447-54. PubMed ID: 13829149
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of uric acid biosynthesis in birds by o-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L-norleucine (DON).
    KRAKOFF IH; KARNOFSKY DA
    Am J Physiol; 1958 Oct; 195(1):244-50. PubMed ID: 13583156
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of azaserine and 6-diazo-5-oxo-L-norleucine on the biosynthesis of inosinic acid de novo.
    BUCHANAN JM
    Tex Rep Biol Med; 1957; 15(1):148-53. PubMed ID: 13409287
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of 6-diazo-5-oxo-L-norleucine on the incorporation of precursors into nucleic acids.
    BARCLAY RK; GARFINKEL E; PHILLIPPS MA
    Cancer Res; 1962 Aug; 22():908-14. PubMed ID: 13864924
    [No Abstract]   [Full Text] [Related]  

  • 5. Alterations in calcium metabolism in cancer patients treated with 6-diazo-5-oxo-L-norleucine.
    MAGILL GB; MYERS WP
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):314-8. PubMed ID: 13379496
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of 6-diazo-5-oxo-L-norleucine and O-diazoacety-L-serine on sarcoma 180.
    CLARKE DA; REILLY HC; STOCK CC
    Antibiot Chemother (Northfield); 1957 Dec; 7(12):653-71. PubMed ID: 24544598
    [No Abstract]   [Full Text] [Related]  

  • 7. Biosynthesis of the purines. XV. The effect of aza-L-serine and 6-diazo-5-oxo-L-norleucine on inosinic acid biosynthesis de novo.
    LEVENBERG B; MELNICK I; BUCHANAN JM
    J Biol Chem; 1957 Mar; 225(1):163-76. PubMed ID: 13416227
    [No Abstract]   [Full Text] [Related]  

  • 8. 6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. I. Biologic studies.
    COFFEY GL; EHRLICH J; FISHER MW; HILLEGAS AB; KOHBERGER DL; MACHAMER HE; RIGHTSEL WA; ROEGNER FR
    Antibiot Chemother (Northfield); 1956 Aug; 6(8):487-97. PubMed ID: 24544086
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 6 diazo 5 oxo l-norleucine on the rat litter in utero.
    THIERSCH JB
    Proc Soc Exp Biol Med; 1957 Jan; 94(1):33-5. PubMed ID: 13400863
    [No Abstract]   [Full Text] [Related]  

  • 10. 6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. V. Microbiologic studies of mode of action.
    MAXWELL RE; NICKEL VS
    Antibiot Chemother (Northfield); 1957 Feb; 7(2):81-9. PubMed ID: 24544268
    [No Abstract]   [Full Text] [Related]  

  • 11. Concentrative uptake of 6-diazo-5-oxo-L-norleucine by sarcoma 180, liver and muscle in vivo.
    JACQUEZ JA
    Proc Soc Exp Biol Med; 1958 Dec; 99(3):611-3. PubMed ID: 13614439
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential anti-cancer agents--II. A proposed mechanism for the anti-cancer action of L-azaserine and 6-diazo-5-oxo-L-norleucine.
    BAKER BR
    Biochem Pharmacol; 1959 Sep; 2():161-7. PubMed ID: 13795976
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects on DON (6-diazo-5-oxo-L-norleucine) and azaserine on the sand-dollar embryo.
    KARNOFSKY DA; BEVELANDER G
    Proc Soc Exp Biol Med; 1958 Jan; 97(1):32-7. PubMed ID: 13518172
    [No Abstract]   [Full Text] [Related]  

  • 14. [Introduction of various new drugs in the treatment of gout by elimination of uric acid].
    DI MAGGIO G
    Omnia Med Suppl; 1954; 6(1):55-70. PubMed ID: 14384207
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of uric acid and its relation to gout.
    HOFFMAN WS
    J Am Med Assoc; 1954 Jan; 154(3):213-7. PubMed ID: 13108698
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of a uricosuric agent associated with the thermal diuresis treatment on uricemia and the excretion of uric acid in 50 hyperuricemic gout patients. Comparison of the action in patients with simple gout and trophic gout].
    MUGLER A
    Rein Foie; 1961 4th Trimest; 2():147-60. PubMed ID: 14476992
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of hydrochlorothiazide on the mechanism of excretion of uric acid. Clinico-experimental observations].
    MASONI A; TOMASI AM; ANTONIOLI G
    Arch Patol Clin Med; 1961 Jul; 37():291-317. PubMed ID: 14470864
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of phenylbutazone on uric acid metabolism.
    MASON RM
    Br Med J; 1954 Apr; 1(4865):788-92. PubMed ID: 13140862
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects.
    YU TF; SIROTA JH; GUTMAN AB
    J Clin Invest; 1953 Nov; 32(11):1121-32. PubMed ID: 13108975
    [No Abstract]   [Full Text] [Related]  

  • 20. The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout.
    Sperling O; Wyngaarden JB; Starmer CF
    J Clin Invest; 1973 Oct; 52(10):2468-85. PubMed ID: 4353999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.